SWOT Analysis for Vivo Bio Tech Ltd. - Weakness

Add SWOT widget to your site/app

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Performer, Under Radar Stocks (DVM)

Undervalued Growth Stocks

Stocks seeing month price declines, good financial durability, and newly affordable valuations (subscription)

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Affordable Stocks - Stocks with Good Trendlyne Valuation Score

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with reducing Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

Promoter holding decreased by more than -2% QoQ

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Oversold by Money Flow Index (MFI)

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Top Losers

Near 52 Week Low

Red Flags: Weakening Technicals and Share Price Decline

Stocks in PE Buy Zone with Reasonable Durability Score, and Rising Momentum Score

Rising Delivery Percentage Compared to Prev Day

Significant Change in Promoter Shareholding - Latest Quarter